Baloxavir Marboxil OverviewBaloxavir marboxil (trade name Xofluza) is an antiviral medication for treatment of influenza A and influenza B FDA-approved in October 2018 and given as a single dose by mouth. It may reduce the duration of flu symptoms by about a day. It was developed by Shionogi Co., a Japanese pharmaceutical company, and Roche AG. Contents 1 Pharmacodynamics 2 Side effects 3 Approval 4 References Pharmacodynamics Baloxavir marboxil is an influenza therapeutic agent (cap-depende...
Read more Baloxavir Marboxil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Baloxavir_marboxil
Recent Baloxavir Marboxil Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 20mg, 40mg
Other drugs which contain Baloxavir Marboxil or a similar ingredient: (1 result)
- XOFLUZA Baloxavir Marboxil